The significance of the complement system for the pathogenesis of age-related macular degeneration — current evidence and translation into clinical application

[1]  M. Yuzawa,et al.  [Polypoidal choroidal vasculopathy]. , 2012, Nippon Ganka Gakkai zasshi.

[2]  K. Matsuo,et al.  CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. , 2010, Investigative ophthalmology & visual science.

[3]  J. Ott,et al.  Progression of geographic atrophy and genotype in age-related macular degeneration. , 2010, Ophthalmology.

[4]  L. Yannuzzi,et al.  Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. , 2010, Ophthalmology.

[5]  Robert B Sim,et al.  Impaired Binding of the Age-related Macular Degeneration-associated Complement Factor H 402H Allotype to Bruch's Membrane in Human Retina* , 2010, The Journal of Biological Chemistry.

[6]  J. Sahel,et al.  Genotypic influences on severity of exudative age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.

[7]  Robert Finger,et al.  Structure-Function Correlation of the Human Central Retina , 2010, PloS one.

[8]  Robert B Sim,et al.  Impaired Binding of the Amd-Associated Complement Factor H 402h Allotype to Bruch’s Membrane in Human Retina , 2010 .

[9]  J. Hollyfield,et al.  A Hapten Generated from an Oxidation Fragment of Docosahexaenoic Acid Is Sufficient to Initiate Age-Related Macular Degeneration , 2010, Molecular Neurobiology.

[10]  Don H. Anderson,et al.  The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited , 2010, Progress in retinal and eye research.

[11]  J. Hollyfield,et al.  Quantitative Proteomics: Comparison of the Macular Bruch Membrane/Choroid Complex from Age-related Macular Degeneration and Normal Eyes , 2010, Molecular & Cellular Proteomics.

[12]  H. Hense,et al.  Susceptibility genes and progression in age-related maculopathy: a study of single eyes. , 2010, Investigative ophthalmology & visual science.

[13]  Augustinus Laude,et al.  Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? , 2010, Progress in Retinal and Eye Research.

[14]  S. Chakrabarti,et al.  The molecular genetic basis of age-related macular degeneration: an overview , 2009, Journal of Genetics.

[15]  B. Rosner,et al.  Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. , 2009, Investigative ophthalmology & visual science.

[16]  Ivana K. Kim,et al.  Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration. , 2009, American journal of ophthalmology.

[17]  D. Pauleikhoff,et al.  Increased vitronectin production by complement-stimulated human retinal pigment epithelial cells. , 2009, Investigative ophthalmology & visual science.

[18]  T. Becker,et al.  CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD , 2009, PloS one.

[19]  I. Constable,et al.  Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration. , 2009, Ophthalmology.

[20]  P. Zipfel.  Complement and immune defense: from innate immunity to human diseases. , 2009, Immunology letters.

[21]  B. Morgan,et al.  The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. , 2009, Human molecular genetics.

[22]  Anand Swaroop,et al.  Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. , 2009, Annual review of genomics and human genetics.

[23]  Johanna M Seddon,et al.  Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.

[24]  B. J. Klevering,et al.  The spectrum of phenotypes caused by variants in the CFH gene. , 2009, Molecular immunology.

[25]  A. Hofman,et al.  Can Dietary Antioxidants Reduce the Genetic Risk of Early Age-Related Macular Degeneration? , 2009 .

[26]  J. Handa,et al.  Changes in Retinal Pigment Epithelium Related to Cigarette Smoke: Possible Relevance to Smoking as a Risk Factor for Age-Related Macular Degeneration , 2009, PloS one.

[27]  M. Pangburn,et al.  Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury* , 2009, The Journal of Biological Chemistry.

[28]  M. Brantley,et al.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy , 2009, Eye.

[29]  A. Negi,et al.  Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. , 2009, Ophthalmology.

[30]  Chi-Chao Chan,et al.  Molecular pathology of age-related macular degeneration , 2009, Progress in Retinal and Eye Research.

[31]  M. Brantley,et al.  Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab , 2008, British Journal of Ophthalmology.

[32]  R. Klein,et al.  American Journal of Epidemiology Original Contribution Combined Effects of Complement Factor H Genotypes, Fish Consumption, and Inflammatory Markers on Long-term Risk for Age-related Macular Degeneration in a Cohort , 2022 .

[33]  J. Forrester,et al.  Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. , 2008, Experimental eye research.

[34]  J. Ott,et al.  Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss , 2008, Journal of Medical Genetics.

[35]  L. Smeeth,et al.  Age-related macular degeneration and complement activation-related diseases: a population-based case-control study. , 2008, Ophthalmology.

[36]  M. Hauser,et al.  Rapid and sensitive method for detection of Y402, H402, I62, and V62 variants of complement factor H in human plasma samples using mass spectrometry. , 2008, Investigative ophthalmology & visual science.

[37]  Martin Oppermann,et al.  Systemic Complement Activation in Age-Related Macular Degeneration , 2008, PloS one.

[38]  E. Souied,et al.  Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes. , 2008, Investigative ophthalmology & visual science.

[39]  J. Haines,et al.  C3 R102G polymorphism increases risk of age-related macular degeneration. , 2008, Human molecular genetics.

[40]  T. Wong,et al.  Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. , 2008, Archives of ophthalmology.

[41]  Thomas J. Lukas,et al.  The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular Degeneration , 2008, PloS one.

[42]  A. Luff,et al.  An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment , 2008, Eye.

[43]  A. Thalamuthu,et al.  Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[44]  J. Ott,et al.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.

[45]  D. Weeks,et al.  C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes , 2008, PloS one.

[46]  C. McCarty,et al.  Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. , 2008, Human molecular genetics.

[47]  J. Tong,et al.  Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[48]  S. Rodríguez de Córdoba,et al.  Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[49]  J. Haines,et al.  Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration. , 2008, Ophthalmology.

[50]  B. J. Klevering,et al.  Basal laminar drusen caused by compound heterozygous variants in the CFH gene. , 2008, American journal of human genetics.

[51]  T. Wong,et al.  Familial aggregation of age-related macular degeneration in the Utah population , 2008, Vision Research.

[52]  N. Orr,et al.  Neovascular Age-Related Macular Degeneration Risk Based on CFH, LOC387715/HTRA1, and Smoking , 2007, PLoS medicine.

[53]  M. Brantley,et al.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. , 2007, Ophthalmology.

[54]  J. Ott,et al.  Haplotypes in the Complement Factor H (CFH) Gene: Associations with Drusen and Advanced Age-Related Macular Degeneration , 2007, PloS one.

[55]  P. Tommila,et al.  The Effect of Complement Factor H Y402H Polymorphism on the Outcome of Photodynamic Therapy in Age-related Macular Degeneration , 2007, European journal of ophthalmology.

[56]  T. Salt,et al.  Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction , 2007, Proceedings of the National Academy of Sciences.

[57]  Johanna M Seddon,et al.  Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.

[58]  M. Brantley,et al.  Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration. , 2007, American journal of ophthalmology.

[59]  J. Haines,et al.  Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. , 2007, Human molecular genetics.

[60]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[61]  U. Schlötzer-Schrehardt,et al.  Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. , 2007, Molecular immunology.

[62]  D. Uhrín,et al.  Structure Shows That a Glycosaminoglycan and Protein Recognition Site in Factor H Is Perturbed by Age-related Macular Degeneration-linked Single Nucleotide Polymorphism* , 2007, Journal of Biological Chemistry.

[63]  R. Kawaguchi,et al.  Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. , 2007, Biochemistry.

[64]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[65]  A. Blom,et al.  The Factor H Variant Associated with Age-related Macular Degeneration (His-384) and the Non-disease-associated Form Bind Differentially to C-reactive Protein, Fibromodulin, DNA, and Necrotic Cells* , 2007, Journal of Biological Chemistry.

[66]  W. März,et al.  Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. , 2007, Ophthalmology.

[67]  J. Forrester,et al.  Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. , 2007, Experimental eye research.

[68]  Don H. Anderson,et al.  Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1 , 2007, The Journal of Immunology.

[69]  C. Keilhauer,et al.  An update on the genetics of age-related macular degeneration , 2007, Molecular vision.

[70]  R. Klein,et al.  CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. , 2006, Human molecular genetics.

[71]  Y. Jang,et al.  Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium , 2006, Proceedings of the National Academy of Sciences.

[72]  N. Orr,et al.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.

[73]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration , 2006 .

[74]  Victoria A. Higman,et al.  His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form* , 2006, Journal of Biological Chemistry.

[75]  A. Hofman,et al.  Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. , 2006, JAMA.

[76]  Johanna M Seddon,et al.  The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.

[77]  P. Mitchell,et al.  Dietary fatty acids and the 5-year incidence of age-related maculopathy. , 2006, Archives of ophthalmology.

[78]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[79]  D. Clayton,et al.  Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. , 2006, Investigative ophthalmology & visual science.

[80]  Don H. Anderson,et al.  Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration: Characterization, ethnic distribution and evolutionary implications , 2006, Annals of medicine.

[81]  Jian Ge,et al.  CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD , 2005, PLoS medicine.

[82]  G. Silvestri,et al.  Retinal changes associated with type 2 glomerulonephritis , 2005, Eye.

[83]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[85]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[86]  Johanna M Seddon,et al.  The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.

[87]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[89]  Thomas J. Liesegang,et al.  An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration.Hageman GS,∗ Luthert PJ, Chong NHV, Johnson LV, Anderson DH, Mullins RF. Prog Ret Eye Res 2001:20:705–732. , 2002 .

[90]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[91]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[92]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[93]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[94]  E. Rimm,et al.  Prospective study of dietary fat and the risk of age-related macular degeneration. , 2001, The American journal of clinical nutrition.

[95]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  A Hofman,et al.  Genetic risk of age-related maculopathy. Population-based familial aggregation study. , 1998, Archives of ophthalmology.

[97]  P. Mitchell,et al.  Family history and age-related maculopathy: the Blue Mountains Eye Study. , 1998, Australian and New Zealand journal of ophthalmology.

[98]  A. Hofman,et al.  Familial aggregation of age-related maculopathy. , 1997, American journal of ophthalmology.

[99]  Wiklund Ra,et al.  First of two parts , 1997 .

[100]  J M Seddon,et al.  Familial aggregation of age-related maculopathy. , 1997, American journal of ophthalmology.

[101]  R. Gokal,et al.  Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. , 1989, The British journal of ophthalmology.

[102]  N. McKechnie,et al.  Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. , 1989, The British journal of ophthalmology.

[103]  K. Horie-Inoue,et al.  Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration. , 2011, Ophthalmology.

[104]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.

[105]  Laura A. Hecker,et al.  Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. , 2010, Human molecular genetics.

[106]  S. Ennis,et al.  Support for the involvement of complement factor I in age-related macular degeneration , 2010, European Journal of Human Genetics.

[107]  M. Frank,et al.  Therapeutic potential of complement modulation , 2010, Nature Reviews Drug Discovery.

[108]  M. Daly,et al.  Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.

[109]  R. Schlingemann,et al.  Treatment of retinal diseases with VEGF antagonists. , 2009, Progress in brain research.

[110]  Edwin M Stone,et al.  Complement factor H polymorphism p.Tyr402His and cuticular Drusen. , 2007, Archives of ophthalmology.

[111]  Ivana K. Kim,et al.  Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. , 2007, Archives of ophthalmology.

[112]  E. Rimm,et al.  A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. , 2007, Archives of ophthalmology.

[113]  J. Hoh,et al.  Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. , 2006, Human molecular genetics.

[114]  T. Mollnes,et al.  Strategies of therapeutic complement inhibition. , 2006, Molecular immunology.

[115]  B. Rosner,et al.  CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. , 2006, Human heredity.

[116]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[117]  Don H. Anderson,et al.  Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. , 2006, Annals of medicine.

[118]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[119]  R. Klein,et al.  Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye study , 1994, Genetic epidemiology.